Literature DB >> 464650

Therapy of psoriasis with retinoid plus PUVA: clinical and histologic data.

G Heidbreder, E Christophers.   

Abstract

In a group of 40 patients suffering from wide-spread psoriasis oral administration of a retinoid (Ro 10-9359) was followed by PUVA therapy. The clearance rate was increased by 30% as compared to PUVA alone. Except for cheilitis no side effects were seen. Histological analysis in 20 patients before, during and after therapy revealed an intensification of psoriatic tissue changes after retinoid treatment. Loss of corneal layers, massive exoserosis, and neutrophil migration were prominent features. Mitotic counts were not increased by the pretreatment. The increased susceptibility of diseased skin to PUVA as produced by this drug appears to be based on several factors related to the tissue changes revealed by histology.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 464650     DOI: 10.1007/bf00412661

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  26 in total

1.  Systemic use of a new retinoid with and without local dithranol treatment in generalized psoriasis.

Authors:  C E Orfanos; U Runne
Journal:  Br J Dermatol       Date:  1976-07       Impact factor: 9.302

2.  Growth stimulation of cultured postembryonic epidermal cells by vitamin A acid.

Authors:  E Christophers
Journal:  J Invest Dermatol       Date:  1974-12       Impact factor: 8.551

3.  Therapeutic effects of an aromatic retinoic acid analog on chemically induced skin papillomas and carcinomas of mice.

Authors:  W Bollag
Journal:  Eur J Cancer       Date:  1974-11       Impact factor: 9.162

4.  [Oral therapy of psoriasis using two vitamin A acid-derivatives (author's transl)].

Authors:  U Runne; C E Orfanos; H Gartmann
Journal:  Arch Dermatol Forsch       Date:  1973-08-15

5.  Vitamin A acid effects on epidermal mitotic activity, thickness and cellularity in the hairless mouse.

Authors:  J S Zil
Journal:  J Invest Dermatol       Date:  1972-09       Impact factor: 8.551

6.  Mechanisms of parakeratosis.

Authors:  E Christophers; O Braun-Falco
Journal:  Br J Dermatol       Date:  1970-03       Impact factor: 9.302

7.  [Oral psoriasis treatment with a new aromatic retinoid (Ro 10-9359): a multi-centre controlled study of 291 patients (preliminary results) (author's transl)].

Authors:  C E Orfanos; G Goerz
Journal:  Dtsch Med Wochenschr       Date:  1978-02-03       Impact factor: 0.628

8.  Influence of a systemically administered aromatic retinoid (Ro 10-9359) on the light sensitivity.

Authors:  H Ippen; M Hofbauer; S Schauder
Journal:  Derm Beruf Umwelt       Date:  1978

9.  [Retinoid PUVA (RePUVA): systemic combination therapy in psoriasis].

Authors:  C E Orfanos; H Pullmann; W Sterry; M Künzig
Journal:  Z Hautkr       Date:  1978-07-15

10.  [Topical treatment of normal and pathological human skin with vitamin A acid (tretinoin)].

Authors:  G Plewig; H H Wolff; O Braun-Falco
Journal:  Arch Klin Exp Dermatol       Date:  1971
View more
  3 in total

1.  Cyclic AMP and cyclic AMP-dependent protein kinase in mouse skin. I. Systemic effects of retinoids and PUVA.

Authors:  R Kumar; O Holian; V C Weiss; D P West
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

Review 2.  The retinoids. A review of their clinical pharmacology and therapeutic use.

Authors:  C E Orfanos; R Ehlert; H Gollnick
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

Review 3.  Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.